Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TVB-2640 in HER2+ Metastatic Breast Cancer
NCT03179904Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2017
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of denifanstat in breast cancer, sponsored by Mayo Clinic. Started Aug 2017; status: completed.
02
Drugs
denifanstat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03179904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03179904.